Korean J Med.  2009 Apr;76(Suppl 1):S204-S207.

Meningitis following vaccination with yellow-fever vaccine

Affiliations
  • 1Department of Infectious Disease, Keimyung University School of Medicine, Daegue, Korea. 121rsy@dsmc.or.kr
  • 2Division of Arboviruses, Center for Immunology and Pathology, National Institute of Health, Korea Centers for Disease Control and Prevention, Seoul, Korea.
  • 3Department of Laboratory Medicine, Keimyung University School of Medicine, Daegue, Korea.

Abstract

Yellow fever is the original viral hemorrhagic fever (VHF), a pansystemic viral sepsis with viremia, fever, prostration, hepatic, renal, and myocardial injury, hemorrhage, shock, and high lethality. Yellow fever was one of the most feared lethal diseases before the development of an effective vaccine. Yellow fever (YF) can be prevented by an attenuated vaccine. The yellow-fever 17D vaccine developed in the 1930s has been regarded as one of the most successful live attenuated vaccines, with few side effects or adverse events. The adverse effects associated with yellow-fever vaccine are generally mild and include headache, myalgia, and low-grade fever. Recently, however, some cases of severe neurologic disease and multi-organ system disease have been described in individuals who received yellow-fever vaccine. We report the case of a 39-year-old female with meningitis following vaccination with 17D yellow-fever vaccine.

Keyword

Yellow fever; Headache; Meningitis

MeSH Terms

Adult
Female
Fever
Headache
Hemorrhage
Hemorrhagic Fevers, Viral
Humans
Meningitis
Sepsis
Shock
Vaccination
Vaccines, Attenuated
Viremia
Yellow Fever
Vaccines, Attenuated
Full Text Links
  • KJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr